Eur Rev Med Pharmacol Sci 2021; 25 (8): 3150-3150
DOI: 10.26355/eurrev_202104_25716

CircRNA EPB41L2 inhibits tumorigenicity of lung adenocarcinoma through regulating CDH4 by miR-211-5p

S.-J. Zhang, J. Ma, J.-C. Wu, Z.-Z. Hao, Y.-N. Zhang, Y.-J. Zhang

Department of Respiratory Medicine, Huaihe Hospital of Henan University, Kaifeng, China.

The article “CircRNA EPB41L2 inhibits tumorigenicity of lung adenocarcinoma through regulating CDH4 by miR-211-5p, by S.-J. Zhang, J. Ma, J.-C. Wu, Z.-Z. Hao, Y.-N. Zhang, Y.-J. Zhang, published in Eur Rev Med Pharmacol Sci 2020; 24 (7): 3749-3760–DOI: 10.26355/eurrev_202004_20839–PMID: 32329852” has been withdrawn from the authors due to inaccuracies and mistakes.

The Publisher apologizes for any inconvenience this may cause.

https://www.staging.europeanreview.org/article/20839

Free PDF Download

To cite this article

S.-J. Zhang, J. Ma, J.-C. Wu, Z.-Z. Hao, Y.-N. Zhang, Y.-J. Zhang
CircRNA EPB41L2 inhibits tumorigenicity of lung adenocarcinoma through regulating CDH4 by miR-211-5p

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 8
Pages: 3150-3150
DOI: 10.26355/eurrev_202104_25716

Keywords Related articles:

  1. CircRNA EPB41L2 inhibits tumorigenicity of lung adenocarcinoma through regulating CDH4 by miR-211-5p
  2. MicroRNA-365 inhibits the progression of lung adenocarcinoma through targeting ETS1 and inactivating AKT/mTOR pathway
  3. Long noncoding RNA CASC2 inhibits metastasis and epithelial to mesenchymal transition of lung adenocarcinoma via suppressing SOX4
  4. Hsa-miR-337 inhibits non-small cell lung cancer cell invasion and migration by targeting TCF7
  5. Overexpression of HOTTIP promotes proliferation and drug resistance of lung adenocarcinoma by regulating AKT signaling pathway